These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 945124

  • 1. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Hohorst HJ, Peter G, Struck RF.
    Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
    [Abstract] [Full Text] [Related]

  • 2. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
    Takamizawa A, Iwata T, Yamaguchi K, Shiratori O, Harada M.
    Cancer Treat Rep; 1976 Apr; 60(4):361-8. PubMed ID: 1277212
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ring.
    Kutscher B, Niemeyer U, Engel J, Kleemann A, Hilgard P, Pohl J, Scheffler G.
    Arzneimittelforschung; 1995 Mar; 45(3):323-6. PubMed ID: 7741794
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, stereochemistry and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and related compounds.
    Takamizawa A, Matsumoto S, Iwata T, Makino I.
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):1877-91. PubMed ID: 562722
    [No Abstract] [Full Text] [Related]

  • 5. Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative.
    Przybylski M, Ringsdorf H, Lenssen U, Peter G, Voelcker G, Wagner T, Hohorst HJ.
    Biomed Mass Spectrom; 1977 Aug; 4(4):209-15. PubMed ID: 912018
    [Abstract] [Full Text] [Related]

  • 6. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M, Kuśnierczyk H, Budzyński W, Rak J, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1986 Aug; 34(3):275-84. PubMed ID: 3592931
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.
    Misiura K, Kinas RW, Stec WJ, Kusnierczyk H, Radzikowski C, Sonoda A.
    J Med Chem; 1988 Jan; 31(1):226-30. PubMed ID: 3336021
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and cytotoxic activity of pyridylthio, pyridylsulfinyl, and pyridylsulfonyl methyl acrylates.
    Phillips OA, Nelson LA, Knaus EE, Allen TM, Fathi-Afshar R.
    Drug Des Deliv; 1989 Mar; 4(2):121-7. PubMed ID: 2765104
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Studies on cytostatic effect of oxazophosphorine metabolites. Role of phospho- and phosphoramide mustards; practical implications].
    Hładoń B.
    Acta Pol Pharm; 1982 Mar; 39(1-3):185-8. PubMed ID: 7180550
    [No Abstract] [Full Text] [Related]

  • 13. [Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) (author's transl)].
    Norpoth K, Addicks HW, Witting U, Mŭller G, Raidt H.
    Arzneimittelforschung; 1975 Sep; 25(9):1331-6. PubMed ID: 1242654
    [Abstract] [Full Text] [Related]

  • 14. X-ray crystallographic studies of cyclophosphamide (NSC-26271) derivatives.
    Camerman A, Smith HW, Camerman N.
    Cancer Treat Rep; 1976 Apr; 60(4):517-22. PubMed ID: 1277229
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271).
    Montgomery JA, Struck RF.
    Cancer Treat Rep; 1976 Apr; 60(4):381-93. PubMed ID: 945126
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Kuśnierczyk H, Radzikowski C, Paprocka M, Budzyński W, Rak J, Kinas R, Misiura K, Stec W.
    J Immunopharmacol; 1986 Apr; 8(4):455-80. PubMed ID: 3805744
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antitumour activity of stereoisomers of 4-hydroperoxy derivatives of ifosfamide and its bromo analogue.
    Misiura K, Szymanowicz D, Kusnierczyk H, Wietrzyk J, Opolski A.
    Farmaco; 2002 Apr; 57(4):315-9. PubMed ID: 11989810
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
    Fujimoto S, Inagaki J, Horikoshi N, Hoshino A.
    Gan; 1977 Oct; 68(5):543-52. PubMed ID: 201534
    [Abstract] [Full Text] [Related]

  • 19. Two stable Fenton oxidation products of cyclophosphamide (NSC-26271) as precursors of 4-hydroxycyclophosphamide (NSC-196562) under physiologic conditions.
    Benckhuysen C, van der Steen J, Spanjersberg EJ.
    Cancer Treat Rep; 1976 Apr; 60(4):369-72. PubMed ID: 945125
    [Abstract] [Full Text] [Related]

  • 20. Cyclophosphamide- or ifosfamide-treated L 1210 leukaemia cells: immunogenicity, viability and metabolism.
    Skórski T, Kawalec M, Hoser G.
    Folia Biol (Praha); 1986 Apr; 32(5):354-65. PubMed ID: 3506526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.